A Pilot Study to Test Whether Systemic Interferon Gamma Increases Tumor Class I MHC Expression in Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
Phase of Trial: Phase 0
Latest Information Update: 11 Jul 2019
Price : $35 *
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Liposarcoma; Myxoid liposarcoma; Synovial sarcoma
- Focus Biomarker; Pharmacodynamics
- 19 Jun 2019 Status changed from active, no longer recruiting to discontinued.
- 08 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated